MicroRNA-208a: a Good Diagnostic Marker and a Predictor of no-Reflow in STEMI Patients Undergoing Primary Percutaneuos Coronary Intervention

[1]  A. Gray.  011 High-sensitivity cardiac troponin on presentation to rule out myocardial infarction (HiSTORIC): a stepped-wedge cluster randomised controlled trial , 2019, Emergency Medicine Journal.

[2]  A. Gray,et al.  012 Outcomes following confirmed myocardial injury in patients with atrial fibrillation: a post hoc subgroup analysis of the high-STEACS trial , 2019, Emergency Medicine Journal.

[3]  Song Gao,et al.  MicroRNA-208a directly targets Src kinase signaling inhibitor 1 to facilitate cell proliferation and invasion in non-small cell lung cancer , 2019, Molecular medicine reports.

[4]  O. Barbarash,et al.  FOURTH UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION. FOCUS ON THE TYPE 2 MYOCARDIAL INFARCTION , 2018, Fundamental and Clinical Medicine.

[5]  F. Babl,et al.  Variability of outcome measures in trials of intravenous therapy in acute severe paediatric asthma: a systematic review , 2018, Emergency Medicine Journal.

[6]  Jeroen J. Bax,et al.  Fourth universal definition of myocardial infarction (2018). , 2018, European heart journal.

[7]  M. April,et al.  High sensitivity troponin: The Sisyphean pursuit of zero percent miss rate for acute coronary syndrome in the ED , 2018, The American journal of emergency medicine.

[8]  Lang Li,et al.  Relationship between circulating miRNA-30e and no-reflow phenomenon in STEMI patients undergoing primary coronary intervention , 2018, Scandinavian journal of clinical and laboratory investigation.

[9]  Supriyo Chakraborty,et al.  Interplay between miRNAs and human diseases , 2018, Journal of cellular physiology.

[10]  Marco Valgimigli,et al.  [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.] , 2018, Kardiologia polska.

[11]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[12]  J. Lupón,et al.  Prognostic Value of New‐Generation Troponins in ST‐Segment–Elevation Myocardial Infarction in the Modern Era: The RUTI‐STEMI Study , 2017, Journal of the American Heart Association.

[13]  O. Agbulut,et al.  MiRroring the Multiple Potentials of MicroRNAs in Acute Myocardial Infarction , 2017, Front. Cardiovasc. Med..

[14]  Marina C Costa,et al.  Circulating miR-122-5p/miR-133b Ratio Is a Specific Early Prognostic Biomarker in Acute Myocardial Infarction. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[15]  Zhang Yan,et al.  microRNA-208a in an early stage myocardial infarction rat model and the effect on cAMP-PKA signaling pathway , 2016, Molecular medicine reports.

[16]  Ye Tian,et al.  Plasma miR-1, miR-208, miR-499 as potential predictive biomarkers for acute myocardial infarction: An independent study of Han population , 2015, Experimental Gerontology.

[17]  Y. Devaux,et al.  Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain , 2015, Journal of internal medicine.

[18]  C. Di Mario,et al.  Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. , 2014, European heart journal.

[19]  S. Kauppinen,et al.  Development of microRNA therapeutics is coming of age , 2014, EMBO molecular medicine.

[20]  H. White,et al.  High-sensitivity troponin level pre-catheterization predicts adverse cardiovascular outcomes after primary angioplasty for ST-elevation myocardial infarction , 2014, European heart journal. Acute cardiovascular care.

[21]  I. Yurekli,et al.  Geriatric patient profile in the cardiovascular surgery intensive care unit. , 2013, JPMA. The Journal of the Pakistan Medical Association.

[22]  K. Xia,et al.  Circulating microRNAs: A Potential Role in Diagnosis and Prognosis of Acute Myocardial Infarction , 2013, Disease markers.

[23]  C. Norbury,et al.  The Long and Short of MicroRNA , 2013, Cell.

[24]  J. Smith,et al.  Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction , 2013, BMC Cardiovascular Disorders.

[25]  G. Calin,et al.  The mix of two worlds: non-coding RNAs and hormones. , 2013, Nucleic acid therapeutics.

[26]  Gang Wang,et al.  Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction , 2013, Clinics.

[27]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[28]  F. Azuaje,et al.  Use of circulating microRNAs to diagnose acute myocardial infarction. , 2012, Clinical chemistry.

[29]  J. Bauersachs,et al.  Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. , 2011, Journal of molecular and cellular cardiology.

[30]  Volker Hovestadt,et al.  Molecular and Cellular Pathobiology MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing , 2011 .

[31]  Jan A Staessen,et al.  Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease , 2010, Circulation. Cardiovascular genetics.

[32]  Yue Li,et al.  Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. , 2010, European heart journal.

[33]  R. Kloner,et al.  The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion , 2006, Basic Research in Cardiology.

[34]  C. Henrikson,et al.  Chest Pain Relief by Nitroglycerin Does Not Predict Active Coronary Artery Disease , 2003, Annals of Internal Medicine.

[35]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[36]  H. Katus,et al.  Admission Troponin T Level Predicts Clinical Outcomes, TIMI Flow, and Myocardial Tissue Perfusion After Primary Percutaneous Intervention for Acute ST-Segment Elevation Myocardial Infarction , 2001, Circulation.

[37]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[38]  Xi Chen,et al.  Circulating miR-208b: A Potentially Sensitive and Reliable Biomarker for the Diagnosis and Prognosis of Acute Myocardial Infarction. , 2017, Clinical laboratory.

[39]  Hugo A. Katus,et al.  MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction , 2010, Basic Research in Cardiology.

[40]  L. Wallentin,et al.  Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction. , 2004, European heart journal.

[41]  J. Sengupta.  The Nonparametric Approach , 1989 .

[42]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.